Catalyst Pharmaceuticals (CPRX) Long-Term Investments (2018 - 2026)
Catalyst Pharmaceuticals posted quarterly Long-Term Investments of $27.3 million for Q1 2026, up 12.71% year-on-year from $24.2 million in Q1 2025, and up 21.08% on a QoQ basis from $22.5 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) has 6 years of Long-Term Investments data on file, last reported at $27.3 million in Q1 2026.
- For the quarter ending Q1 2026, Long-Term Investments rose 12.71% year-over-year to $27.3 million; the trailing twelve-month figure through Mar 2026 stood at $27.3 million (up 12.71% YoY), and the FY2025 full-year result was $22.5 million, up 4.51% from the prior year.
- Long-Term Investments for Q1 2026 stood at $27.3 million, up from $22.5 million in the prior quarter.
- Across five years, Long-Term Investments topped out at $27.3 million in Q1 2026 and bottomed at $12.9 million in Q3 2023.
- The 4-year median for Long-Term Investments is $19.2 million (2025), against an average of $19.0 million.
- Peak annual rise in Long-Term Investments reached 62.47% in 2025, while the deepest fall reached 4.51% in 2025.
- A 4-year view of Long-Term Investments shows it stood at $16.5 million in 2023, then surged by 30.78% to $21.6 million in 2024, then rose by 4.51% to $22.5 million in 2025, then increased by 21.08% to $27.3 million in 2026.
- The last three Long-Term Investments figures came in at $27.3 million (Q1 2026), $22.5 million (Q4 2025), and $19.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 505,194.89 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 5.75 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 9.79 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 22.17 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 27.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 27.29 Mn |
| Dec 31, 2025 | 22.54 Mn |
| Sep 30, 2025 | 19.17 Mn |
| Jun 30, 2025 | 21.26 Mn |
| Mar 31, 2025 | 24.21 Mn |
| Dec 31, 2024 | 21.56 Mn |
| Sep 30, 2024 | 14.84 Mn |
| Jun 30, 2024 | 13.08 Mn |
| Mar 31, 2024 | 15.35 Mn |
| Dec 31, 2023 | 16.49 Mn |
| Sep 30, 2023 | 12.90 Mn |
| Sep 30, 2019 | 5.01 Mn |
| Jun 30, 2019 | 5.01 Mn |
| Mar 31, 2019 | 4.99 Mn |
| Dec 31, 2018 | 5.01 Mn |
| Sep 30, 2018 | 5.02 Mn |
| Jun 30, 2018 | 5.01 Mn |